Last reviewed · How we verify
NCT05734716: COAST
Colorado-Oregon Altitude Study
Phase 4 trial testing Erythropoietin in Acute Mountain Sickness in 121 participants. Completed in 1 January 2023.
1 August 2022
Quick facts
| Lead sponsor | University of Oregon |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 121 |
| Start date | 17 February 2021 |
| Primary completion | 1 August 2022 |
| Estimated completion | 1 January 2023 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Erythropoietin — full drug profile →
- Iron sucrose (Venofer) — full drug profile →
- Sterile Sodium Chloride — full drug profile →
Conditions studied
- Acute Mountain Sickness — all drugs for Acute Mountain Sickness →
Sponsor
University of Oregon
Who can join
Adults 18 to 40, any sex, with Acute Mountain Sickness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Investigating the utility of prophylactic treatment with iron sucrose and/or erythropoietin on the prevention of acute mountain sickness in fit, young, healthy individuals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05734716
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Erythropoietin
Trials testing the same drug.
- NCT06983756 — " Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Out · not yet recruiting
- NCT06590155 — Erythropoietin in HIE Neonate · EARLY_PHASE1 · not yet recruiting
- NCT06542393 — PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG) · Phase 2 · recruiting
- NCT05395195 — Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial) · Phase 3 · recruiting
- NCT05300477 — Pharmacological Countermeasures for High Altitude · Phase 4 · active not recruiting
Other recruiting trials for Acute Mountain Sickness
Currently open trials in the same condition.
- NCT07126834 — Voluntary Isocapnic Hyperpnea in Hypoxia to Mitigate Acute Mountain Sickness · NA · active not recruiting
- NCT06499714 — HighCycle Study: Effect of High Altitude on Acute Mountain Sickness in Women Related to Their Menstrual Cycle Phase · recruiting
Other University of Oregon trials
Trials by the same sponsor.
- NCT07529327 — Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups an · NA · recruiting
- NCT07471633 — Piloting a Learning Collaborative for School-Based Bilingual Providers Delivering Evidence-Based Interventions · NA · not yet recruiting
- NCT07264621 — The University of Oregon ACCESS Project · NA · enrolling by invitation
- NCT07025083 — Adaptation of the Family Check-Up Online · NA · recruiting
- NCT06843200 — Conversations With Caregivers About Health and Appearance · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05734716 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oregon
- Last refreshed: 10 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05734716.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing